Genmab A/S (GMAB) Insider Trading & Ownership

$28.47
-0.09 (-0.32%)
(As of 04/24/2024 ET)

There is no recent insider trading on record for Genmab A/S, but the stock has been recently traded by U.S. Congress members, who may have more information about the industry than the general public.

Get GMAB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Genmab A/S stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Genmab A/S Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellAverage Share PriceTotal Transaction
10/16/2023Josh GottheimerU.S. Congress Member (D-NJ)Buy$32.55$1,001 - $15,000
9/15/2023Josh GottheimerU.S. Congress Member (D-NJ)Sell$37.98$1,001 - $15,000
7/20/2023Josh GottheimerU.S. Congress Member (D-NJ)Buy$41.45$1,001 - $15,000
7/19/2023Josh GottheimerU.S. Congress Member (D-NJ)Buy$40.90$1,001 - $15,000
7/10/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$37.86$50,001 - $100,000
3/31/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$37.76$1,001 - $15,000
(Data available from 1/1/2013 forward)

GMAB Insider Trading Activity - Frequently Asked Questions

What percentage of Genmab A/S stock is owned by insiders?

1.54% of Genmab A/S stock is owned by insiders. Learn more on GMAB's insider holdings.

Which members of congress are trading Genmab A/S?

Josh Gottheimer (D-NJ) has bought shares of Genmab A/S in the last year totaling $24,000. Josh Gottheimer (D-NJ) and Daniel S. Goldman (D-NY) have sold shares totaling $83,000.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:GMAB) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners